Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Equity Average (2018 - 2025)

Catheter Precision (VTAK) has disclosed Equity Average for 8 consecutive years, with $6.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average fell 52.11% to $6.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.5 million, a 52.11% decrease, with the full-year FY2024 number at $16.5 million, up 8.2% from a year prior.
  • Equity Average was $6.5 million for Q3 2025 at Catheter Precision, down from $7.2 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $29.8 million in Q2 2023 to a low of $6.5 million in Q3 2025.
  • A 5-year average of $16.3 million and a median of $16.4 million in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: surged 113.82% in 2023, then tumbled 55.95% in 2025.
  • Catheter Precision's Equity Average stood at $17.6 million in 2021, then plummeted by 38.19% to $10.9 million in 2022, then soared by 97.8% to $21.5 million in 2023, then crashed by 42.91% to $12.3 million in 2024, then plummeted by 47.13% to $6.5 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Equity Average are $6.5 million (Q3 2025), $7.2 million (Q2 2025), and $9.8 million (Q1 2025).